Posts Tagged ‘DEA’

DFWHC Foundation’s virtual “Opioid Discussion” is this Wednesday!

The DFW Hospital Council (DFWHC) Foundation will continue its live virtual “Opioid Discussion” with the topic “Opioids and the Overdose Epidemic- Fentanyl Epidemic and the High Cost of the Opioids” this Wednesday, July 13 from 2:00 p.m. – 3:00 p.m., CST. During this session, speakers will discuss factors contributing to the misuse of and addiction […]

DFWHC Foundation’s virtual “Opioid Discussion” continues July 13

The DFW Hospital Council (DFWHC) Foundation will continue its live virtual “Opioid Discussion” with the topic “Opioids and the Overdose Epidemic- Fentanyl Epidemic and the High Cost of the Opioids” on Wednesday, July 13 from 2:00 p.m. – 3:00 p.m., CST. During this session, speakers will discuss factors contributing to the misuse of and addiction […]

DFWHC Foundation’s virtual “Opioid Discussion” is one week away on March 29

The DFW Hospital Council (DFWHC) Foundation will continue its live virtual “Opioid Discussion” with the topic “Opioids and the Overdose Epidemic” in one week on Tuesday, March 29 from 2:00 p.m. – 3:00 p.m., CST. Guest speaker will be Lisa Sullivan, Drug Enforcement Administration Dallas Diversion Program Manager. During this session, Sullivan will discuss factors […]

DFWHC Foundation’s virtual “Opioid Discussion” to continue March 29

The DFW Hospital Council (DFWHC) Foundation will continue its live virtual “Opioid Discussion” with the topic “Opioids and the Overdose Epidemic” on Tuesday, March 29 from 2:00 p.m. – 3:00 p.m., CST. Guest speaker will be Lisa Sullivan, Drug Enforcement Administration Dallas Diversion Program Manager. During this session, Sullivan will discuss factors contributing to the […]

DEA creates a COVID-19 information page

The Drug Enforcement Administration (DEA) released a statement today detailing its new information page that went live this week. The statement: The mission of Drug Enforcement Administration (DEA), Diversion Control Division is to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply […]